Written by Sarah McGruddy

Source & Study Reference

https://doi.org/10.1038/s41598-026-38091-9

Garcia-Romeu, A., Naudé, G. P., Rebman, A. W., So, S., Yaffe, A., Geithner, I., … & Aucott, J. N. (2026). Pilot study of psilocybin in patients with post-treatment lyme disease. Scientific reports, 16(1), 7497.


Introduction: Psilocybin as a Therapeutic Tool

Psilocybin (the psychoactive compound found in magic mushrooms) has been increasingly used in recent years as a therapeutic tool. Research has explored its effects across a range of mental health conditions – from depression and anxiety, to PTSD and substance use disorders. More recently, attention has begun to shift toward its potential role in treatment of physical ailments such as chronic pain and inflammation-related conditions.

A new study by Garcia-Romeu et al. (2026) from Johns Hopkins University has preliminary results on the effects of psilocybin in those with post-treatment Lyme disease (PTLD).


What is Post-Treatment Lyme Disease (PTLD)?

Post-treatment Lyme disease develops in about 10-20% of people initially diagnosed with Lyme disease. Although most people respond well to standard antibiotic treatment, some do not fully recover and therefore develop PTLD.

PTLD is not fully understood and its underlying mechanisms are being constantly questioned. It is characterized as a chronic, life-long syndrome, marked by symptoms of fatigue, pain, cognitive difficulties, mood disturbances, and reduced quality of life.

Because there is no universally effective treatment, improving symptoms are typically the focus of research and care.


Why Consider Psilocybin for Lyme Disease Symptoms?

Because of the success of psilocybin in treating similar symptoms in recent clinical trials, it was hypothesized that psilocybin might be able to reduce symptoms in those with PTLD. In particular:

  • Mood improvement: psilocybin has shown robust effects in treating symptoms of depression and anxiety
  • Anti-inflammatory: psilocybin is proposed to influence inflammatory pathways
  • Pain perception: psilocybin is being piloted in study to modulate pain perception

Study Design

This was a small, open-label pilot study – meaning no placebo group and no blinding of participants or researchers.

Participants underwent an 8-week treatment period of:

  • Initial dose of 15mg of psilocybin combined with psychological support
  • Secondary dose of 15-25mg of psilocybin also with structured psychological support

Results of the Psilocybin PTLD Study

Although preliminary, results were encouraging:

  • Significant improvement in quality of life at both 1-month and 6-month follow ups
  • Significant improvement of PTLD symptom burden at both 1-month and 6-month follow ups

At 6 months participants also reported fatigue and pain reduced, while mood and sleep quality improved.

These findings suggest that psilocybin may be able to address not only the mental health symptoms of PTLD but also the physical and functional aspects of this chronic illness.


Discussion: What Do These Findings Mean?

These preliminary results suggest that psilocybin has the potential to aid in relief of both cognitive and physical symptoms of chronic diseases such as Post-treatment Lyme disease. Also, a mentionable note is the durability of results (lasting up to 6 months) following the initial doses.

Researchers from this study have indicated further avenues for research understanding the changes in biomarkers following psilocybin ingestion, alongside qualitative reports from the participants themselves.

However, it is important to not that it was a pilot study with a small sample size and no control group – limiting the conclusions that can be made. Placebo effects, expectancy, and the therapeutic context may all be contributing factors to the improvement in symptoms.


Learn More About Psilocybin & Microdosing

If you’re interested in the potential of psilocybin beyond clinical research, it’s important to understand how it’s being explored in everyday settings.

For a deeper understanding, you can read our Microdosing Magic Truffles: The Ultimate Guide to Microdosing, where we break down how microdosing works, common protocols, and what to expect.

If you’re considering getting started, you can also explore our magic truffles and starter kits designed for beginners who want a structured and controlled introduction.

For additional support, especially for those new to psychedelic experiences, many people choose to keep a Trip Stopper on hand as a precautionary tool.


Follow Microdose Bros

Stay connected and be part of the journey. We share insights on microdosing, psychedelic education, new products, and behind-the-scenes moments from our shop in Utrecht.

Follow us on your favorite platform:

Join our community and stay inspired.